Surgery is a discipline which profoundly affects human integrity. Therefore, there is an ethical and scientific imperative that surgical practice depends on the best possible trial-based evidence. Traditionally, the quality and quantity of clinical research have been lagging behind other disciplines in clinical medicine. However, recent collaborative initiatives, such as the IDEAL framework which tests surgical innovation, international registries, and quality assurance platforms, the development of modified randomized controlled trials and alternative trial designs as well as the impending reforms of the regulatory framework surrounding nonpharmaceutical interventions and devices offer significant and timely opportunities to enhance the relevance of clinical research in surgery. Here, we provide an overview of the current state of clinical research in surgery, identify possible obstacles, and discuss realistic and emerging solutions that have the potential to change the way surgical research is organized, funded, and translated to the patient's benefit.

Keywords:
Research, Randomized trial, Surgery, Evidence
1.
Smythe WR: The future of academic surgery. Acad Med 2010;85:768-774.
2.
Horton R: Surgical research or comic opera: questions, but few answers. Lancet 1996;347:984-985.
3.
STREPTOMYCIN treatment of pulmonary tuberculosis. Br Med J 1948;2:769-782.
4.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-639.
5.
Schulz KF, Altman DG, Moher D; CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18.
6.
To MJ, Jones J, Emara M, Jadad AR: Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals. PLoS One 2013;8:e84779.
7.
Sivendran S, Latif A, McBride RB, Stensland KD, Wisnivesky J, Haines L, Oh WK, Galsky MD: Adverse event reporting in cancer clinical trial publications. J Clin Oncol 2014;32:83-89.
8.
Grellety T, Petit-Moneger A, Diallo A, Mathoulin-Pelissier S, Italiano A: Quality of reporting of phase II trials: a focus on highly ranked oncology journals. Ann Oncol 2014;25:536-541.
9.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
10.
Adie S, Harris IA, Naylor JM, Mittal R: CONSORT compliance in surgical randomized trials: are we there yet? A systematic review. Ann Surg 2013;258:872-878.
11.
Liu LQ, Morris PJ, Pengel LH: Compliance to the CONSORT statement of randomized controlled trials in solid organ transplantation: a 3-year overview. Transpl Int 2013;26:300-306.
12.
Nagendran M, Harding D, Teo W, Camm C, Maruthappu M, McCulloch P, Hopewell S: Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): a cross-sectional study. BMJ Open 2013;3:e003898.
13.
Gray R, Sullivan M, Altman DG, Gordon-Weeks AN: Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study. Ann R Coll Surg Engl 2012;94:388-394.
14.
Wenner DM, Brody BA, Jarman AF, Kolman JM, Wray NP, Ashton CM: Do surgical trials meet the scientific standards for clinical trials? J Am Coll Surg 2012;215:722-730.
15.
Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blumle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-Gonzalez I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M: Completion and publication rates of randomized controlled trials in surgery: an empirical study. Ann Surg 2014, Epub ahead of print.
16.
Strobel O, Buchler MW: The problem of the poor control arm in surgical randomized controlled trials. Br J Surg 2013;100:172-173.
17.
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-1200.
18.
Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA: An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med 1959;260:1115-1118.
19.
Edwards JP, Kelly EJ, Lin Y, Lenders T, Ghali WA, Graham AJ: Meta-analytic comparison of randomized and nonrandomized studies of breast cancer surgery. Can J Surg 2012;55:155-162.
20.
Peinemann F, Tushabe DA, Kleijnen J: Using multiple types of studies in systematic reviews of health care interventions - a systematic review. PLoS One 2013;8:e85035.
21.
Potter S, Mills N, Cawthorn SJ, Donovan J, Blazeby JM: Time to be BRAVE: is educating surgeons the key to unlocking the potential of randomised clinical trials in surgery? A qualitative study. Trials 2014;15:80.
22.
Kaur G, Hutchison I, Mehanna H, Williamson P, Shaw R, Tudur Smith C: Barriers to recruitment for surgical trials in head and neck oncology: a survey of trial investigators. BMJ Open 2013;3:e002625.
23.
Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, Abdu WA, Hilibrand AS, Boden SD, Deyo RA: Surgical vs. nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 2006;296:2441-2450.
24.
Thompson JE, Egger S, Bohm M, Haynes AM, Matthews J, Rasiah K, Stricker PD: Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases. Eur Urol 2014;65:521-531.
25.
Le Morvan P, Stock B: Medical learning curves and the Kantian ideal. J Med Ethics 2005;31:513-518.
26.
Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069-2077.
27.
Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KG: Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 2001;88:1157-1168.
28.
Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, Blazeby JM: Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 2012;255:658-666.
29.
Chan S, Bhandari M: The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. J Bone Joint Surg Am 2007;89:1970-1978.
30.
Majeed AW, Troy G, Nicholl JP, Smythe A, Reed MW, Stoddard CJ, Peacock J, Johnson AG: Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet 1996;347:989-994.
31.
Sihvonen R, Paavola M, Malmivaara A, Itala A, Joukainen A, Nurmi H, Kalske J, Jarvinen TL; Finnish Degenerative Meniscal Lesion Study G: Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med 2013;369:2515-2524.
32.
Mann M, Tendulkar A, Birger N, Howard C, Ratcliffe MB: National institutes of health funding for surgical research. Ann Surg 2008;247:217-221.
33.
Ratcliffe MB, Howard C, Mann M, del Nido P: National Institutes of Health funding for cardiothoracic surgical research. J Thorac Cardiovasc Surg 2008;136:392-397; discussion 398-399.
34.
McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D: Randomised trials in surgery: problems and possible solutions. BMJ 2002;324:1448-1451.
35.
Jarman AF, Wray NP, Wenner DM, Ashton CM: Trials and tribulations: the professional development of surgical trialists. Am J Surg 2012;204:339-346.e5.
36.
Challoner DR, Vodra WW: Medical devices and health - creating a new regulatory framework for moderate-risk devices. N Engl J Med 2011;365:977-979.
37.
Campillo-Artero C: A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe. Health Policy 2013;113:38-44.
38.
Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
39.
Glasziou P, Chalmers I, Rawlins M, McCulloch P: When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349-351.
40.
Lassen K, Hvarphiye A, Myrmel T: Randomised trials in surgery: the burden of evidence. Rev Recent Clin Trials 2012;7:244-248.
41.
Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas WB: Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol 2006;6:29.
42.
Adamina M, Guller U, Weber WP, Oertli D: Propensity scores and the surgeon. Br J Surg 2006;93:389-394.
43.
Brown CA, Lilford RJ: The stepped wedge trial design: a systematic review. BMC Med Res Methodol 2006; 6:54.
44.
Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, Seiler CM, Balliol C, Altman DG, Aronson JK, Barkun JS, Campbell WB, Cook JA, Feldman LS, Flum DR, Glasziou P, Maddern GJ, Marshall JC, McCulloch P, Nicholl J, Strasberg SM, Meakins JL, Ashby D, Black N, Bunker J, Burton M, Campbell M, Chalkidou K, Chalmers I, de Leval M, Deeks J, Grant A, Gray M, Greenhalgh R, Jenicek M, Kehoe S, Lilford R, Littlejohns P, Loke Y, Madhock R, McPherson K, Rothwell P, Summerskill B, Taggart D, Tekkis P, Thompson M, Treasure T, Trohler U, Vandenbroucke J: Challenges in evaluating surgical innovation. Lancet 2009;374:1097-1104.
45.
McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, Nicholl J, Balliol C, Aronson JK, Barkun JS, Blazeby JM, Boutron IC, Campbell WB, Clavien PA, Cook JA, Ergina PL, Feldman LS, Flum DR, Maddern GJ, Nicholl J, Reeves BC, Seiler CM, Strasberg SM, Meakins JL, Ashby D, Black N, Bunker J, Burton M, Campbell M, Chalkidou K, Chalmers I, de Leval M, Deeks J, Ergina PL, Grant A, Gray M, Greenhalgh R, Jenicek M, Kehoe S, Lilford R, Littlejohns P, Loke Y, Madhock R, McPherson K, Meakins J, Rothwell P, Summerskill B, Taggart D, Tekkis P, Thompson M, Treasure T, Trohler U, Vandenbroucke J: No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009;374: 1105-1112.
46.
Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A, IDEAL Group: IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 2013;346:f2820.
47.
Ergina PL, Barkun JS, McCulloch P, Cook JA, Altman DG; IDEAL Group: IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ 2013;346:f3011.
48.
McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK; IDEAL Group: IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 2013;346:f3012.
49.
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. http://www.comet-initiative.org/.
50.
Macefield RC, Boulind CE, Blazeby JM: Selecting and measuring optimal outcomes for randomised controlled trials in surgery. Langenbecks Arch Surg 2014;399:263-272.
51.
Antonescu I, Mueller CL, Fried GM, Vassiliou MC, Mayo NE, Feldman LS: Outcomes reported in high-impact surgical journals. Br J Surg 2014;101:582-589.
52.
Waljee J, McGlinn EP, Sears ED, Chung KC: Patient expectations and patient-reported outcomes in surgery: a systematic review. Surgery 2014;155:799-808.
53.
van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, Bonjer HJ; Group COcLoORIS: Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210-218.
54.
Cook JA, Ramsay CR, Fayers P: Statistical evaluation of learning curve effects in surgical trials. Clin Trials 2004;1:421-427.
55.
Soreide K, Alderson D, Bergenfelz A, Beynon J, Connor S, Deckelbaum DL, Dejong CH, Earnshaw JJ, Kyamanywa P, Perez RO, Sakai Y, Winter DC; International Research Collaboration in Surgery ad-hoc working group: Strategies to improve clinical research in surgery through international collaboration. Lancet 2013;382:1140-1151.
56.
Knebel P, Kuhn S, Ulrich AB, Buchler MW, Diener MK: The Study Centre of the German Surgical Society: current trials and results. Langenbecks Arch Surg 2012;397:611-618.
57.
Royal College of Surgeons of England: The Rosetrees and the RCS clinical trials initiative. www.rcseng.ac.uk/surgeons/research/surgical-research/surgical-clinical-trials.
58.
Neuman HB, Greenberg CC: Comparative effectiveness research: opportunities in surgical oncology. Semin Radiat Oncol 2014;24:43-48.
59.
Bakaeen FG, Reda DJ, Gelijns AC, Cornwell L, Omer S, Al Jurdi R, Kougias P, Anaya D, Berger DH, Huang GD: Department of Veterans Affairs Cooperative Studies Program Network of Dedicated Enrollment Sites: implications for surgical trials. JAMA Surg 2014, Epub ahead of print.
60.
Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, Gerstel E, Roth A, Majno PE, Mentha G: A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012;256:772-778; discussion 778-779.
61.
Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH: Worldwide esophageal cancer collaboration. Dis Esophagus 2009;22:1-8.
62.
Breugom AJ, Boelens PG, van den Broek CB, Cervantes A, Van Cutsem E, Schmoll HJ, Valentini V, van de Velde CJ: Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 2014;25;1485-1492.
63.
Urquhart R, Grunfeld E, Jackson L, Sargeant J, Porter GA: Cross-disciplinary research in cancer: an opportunity to narrow the knowledge-practice gap. Curr Oncol 2013;20:e512-e521.
64.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-1457.
65.
European Commission press release, September 26, 2012. Safer, more effective and innovative medical devices. http://ec.europa.eu/health/medical-devices/files/revision_docs/pr_20120926_en.pdf.
66.
A Delicate Balance: FDA and the Reform of the Medical Device Approval Process. http://www.fda.gov/NewsEvents/Testimony/ucm250709.htm.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.